Moreover, EZH2, a transcriptional repressor of several anti-proliferative genes, has been shown to undergo methylation by SMYD2, leading to EZH2 stability and therefore enhancing cell proliferation in breast cancer [6, 14]. This evidence concerns the gene EZH2 and breast cancer.